Counsyl, a Silicon Valley company that screens prospective parents for their risk of passing on rare inherited diseases, has expanded its genetic testing service to assess your inherited risks for breast, ovarian, prostate, and pancreatic cancers. The expanded testing, which arrived on the heels of $28 million in new funding raised from Goldman Sachs and others, comes in the midst of a national discussion over the proper role of genetic testing in preventative medicine. Counsyl’s take is summed up by its new tagline — "It’s good to know." But is it?
via The Verge - All Posts http://ift.tt/1joeT5g
No comments:
Post a Comment